Rhumbline Advisers Calyxt, Inc. Transaction History

Rhumbline Advisers

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.83 - $6.31 $47,679 - $78,553	-12,449 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$3.21 - $5.68 $11,681 - $20,669	-3,639 Reduced 22.62%	12,449 $53,000
Q3 2020 Nov 12, 2020	SELL	$4.37 - $7.66 $15,884 - $27,844	-3,635 Reduced 18.43%	16,088 $88,000
Q2 2020 Aug 13, 2020	BUY	$2.9 - $6.36 $27,332 - $59,943	9,425 Added 91.52%	19,723 $97,000
Q4 2019 Feb 05, 2020	BUY	$3.6 - $7.27 $37,072 - $74,866	10,298 New	10,298 $72,000
Q3 2019 Oct 23, 2019	SELL	$5.64 - $12.82 $56,783 - $129,071	-10,068 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.24 - $17.4 $123,232 - $175,183	10,068 New	10,068 $126,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.